Brazil's National Health Surveillance Agency (Anvisa) has approved the use of the drug donanemabe to slow the progression of ...

A new study has found why MRI scans may leave harmful metals behind in a person's body. The University of New Mexico (UNM) study explored health risks caused by toxic rare earth metal gadolinium ...

MRI scans could turn dangerous when gadolinium meets common food molecules, forming harmful nanoparticles in the body. A toxic metal used in MRI scans may pose greater health risks than previously ...

Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by binding to and removing beta-amyloid plaques through various mechanisms ...

Mivelsiran that is in phase II clinical trial for cerebral amyloid angiopathy, and phase I clinical trial for Alzheimer’s disease; and ALN-HTT02 that is in phase I clinical trial for Huntington’s ...

CD47 is found to play a pivotal role in this immunosuppression by inducing the production of amyloid-β (Aβ), which interacts with CD74 on B cells, leading to B-cell suppression and subsequent adaptive ...

An early look at the phase 1b/2a data showed amyloid levels fell below a disease threshold in 81% of patients after 28 weeks. The Swiss drugmaker has identified the speed at which amyloid is ...

Amyloid β1‐40 (Aβ1‐40) contributes to atherosclerosis, being involved in plaque formation and destabilization. The prognostic role of Aβ1‐40 in patients with acute myocardial infarction is currently ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

investigated the relationship between anticoagulant use and the location and etiology of intracerebral hemorrhage (ICH), focusing on whether hypertensive microangiopathy or cerebral amyloid angiopathy ...